HUNTINGTON STATION, NY--(Marketwire - November 19, 2008) - Medivisor, Inc. (PINKSHEETS: MVSR), developer of next-generation focus driven marketing tools, sales strategies, and distribution platforms, announced today that it has entered into an agreement with The Curry Group, agent for Nico Worldwide Inc., for the sale and marketing of NICLite®. NICLite® is an alcohol-free Smoking Alternative Drink that is registered with the FDA as a Homeopathic Nicotinum Complex Formula.

Over 2.5 billion people (close to half the world's population) smoke cigarettes. This includes an astounding 48.2 million Americans. Throughout the world, legislation is demanding a ban on smoking. As confirmed in the New England Journal of Medicine, nicotine is a naturally occurring compound. It is found in common foods and vegetables such as potatoes, tomatoes, cauliflower, eggplant, chili peppers, and some types of tea. The World Health Organization has estimated that tobacco smoke contains over 4,000 chemicals, of which nicotine is just one. In addition to tar, there is also carbon monoxide (found in car exhaust fumes), ammonia (found in floor cleaner) and arsenic (found in rat poison). At least 43 of the chemicals in tobacco smoke are known to cause cancers of the lung, throat, mouth, bladder and kidneys. Tobacco smoke also contributes to a number of other cancers.

NICLite® contains a purified organic nicotine molecule in a Complex Homeopathic Formula, which will go into equal suspension in 8 ounces of pharmaceutical grade water. Nico Worldwide Inc. developed NICLite® as a smoking alternative for when people can't smoke, shouldn't smoke or choose not to smoke, and to reduce the craving for tobacco.

"With an increasing number of places and countries banning smoking, NICLite® offers people a real alternative, and the ability to live life smoke free," stated Dino Luzzi, president of Medivisor, Inc. "The potential marketplace for this product is almost limitless."

About Medivisor, Inc.:

Medivisor, Inc., is a developer of next-generation focus driven marketing tools, dedicated to providing technologies that offer innovative and competitive advantages to the bioscience and pharmaceutical markets. From pre-product development through product launch and commercialization, Medivisor offers worldwide experience in delivering effective and successful integrated marketing and creative communications campaigns for the benefit of its clients.

Safe Harbor

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act") Additionally, words such as "seek," "intend," "believe," "plan," "estimate," "expect," "anticipate" and other similar expressions are forward-looking statements within the meaning of the Act. Some or all of the events or results anticipated by these forward-looking statements may not occur. Further information on Medivisor risk factors is contained in its filings with the Securities and Exchange Commission. Medivisor does not undertake any duty nor does it intend to update the results of these forward-looking statements.

Contact Information: Contact: Dino Luzzi CEO Medivisor, Inc. Tel: 631.549.7100